Sofinnova Raises €445m To Help European Biotechs Reach Critical Mass - And SPACs Are A Welcome Innovation

Funds To Fuel Maturing Firms

 
• By Andrew McConaghie

VC’s new fundraising is oversubscribed, reflecting growing confidence in developing European biotech sector.

Paris
Paris is home to a growing number of biotech companies - but major funding is still hard to come by compared to the US.

More from Start-Ups & SMEs

More from Business